Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuele Spadafora

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Respiratory Physiology & Neurobiology|March 18, 2018
Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with LevosimendanJeness Campodonico, Massimo Mapelli, Emanuele Spadafora, et al.
ESC Heart Failure|November 25, 2017
Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigueMarco Morosin, Stefania Farina, Carlo Vignati, et al.
Scientific Reports|April 30, 2020
Effects of β<sub>2</sub>-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trialMauro Contini, Emanuele Spadafora, Simone Barbieri, et al.
Respiratory Physiology & Neurobiology|June 9, 2020
Variability in pulmonary diffusing capacity in heart failureAlessandra Magini, Mauro Contini, Emanuele Spadafora, et al.
European Journal of Preventive Cardiology|April 27, 2019
Do rebreathing manoeuvres for non-invasive measurement of cardiac output during maximum exercise test alter the main cardiopulmonary parameters?Carlo Vignati, Marco Morosin, Laura Fusini, et al.
Journal of the American College of Cardiology|December 15, 2015
Acute Increase of Cardiac Output Reduces Central Sleep Apneas in Heart Failure PatientsPiergiuseppe Agostoni, Mauro Contini, Carlo Vignati, et al.
European Journal of Heart Failure|February 25, 2017
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score databaseStefania Paolillo, Massimo Mapelli, Alice Bonomi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Respiratory Physiology & Neurobiology|March 18, 2018
Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with LevosimendanJeness Campodonico, Massimo Mapelli, Emanuele Spadafora, et al.
ESC Heart Failure|November 25, 2017
Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigueMarco Morosin, Stefania Farina, Carlo Vignati, et al.
Scientific Reports|April 30, 2020
Effects of β<sub>2</sub>-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trialMauro Contini, Emanuele Spadafora, Simone Barbieri, et al.
Respiratory Physiology & Neurobiology|June 9, 2020
Variability in pulmonary diffusing capacity in heart failureAlessandra Magini, Mauro Contini, Emanuele Spadafora, et al.
European Journal of Preventive Cardiology|April 27, 2019
Do rebreathing manoeuvres for non-invasive measurement of cardiac output during maximum exercise test alter the main cardiopulmonary parameters?Carlo Vignati, Marco Morosin, Laura Fusini, et al.
Journal of the American College of Cardiology|December 15, 2015
Acute Increase of Cardiac Output Reduces Central Sleep Apneas in Heart Failure PatientsPiergiuseppe Agostoni, Mauro Contini, Carlo Vignati, et al.
European Journal of Heart Failure|February 25, 2017
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score databaseStefania Paolillo, Massimo Mapelli, Alice Bonomi, et al.
Pageof 1